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Cellular responses to environmental cues are mediated through
complex networks of signal transduction pathways. Among the
molecules involved in these pathways, members of the protein
kinase C (PKC) family stand out because of their ability to acutely
and reversibly modulate effector protein functions and control
the spatial distribution and dynamic properties of the signals.
PKC enzymes also contribute to signaling networks that coor-
dinate many aspects of immune cell function and, therefore, are
important players in immune regulation.
Originally discovered in 1977, by Nishizuka and coworkers,
PKC was initially identified as a cyclic nucleotide-independent
protein kinase that is capable of phosphorylating histone and
protamine following Ca2+-dependent limited proteolysis of its
proenzyme precursor (1, 2). Subsequently, Nishizuka demon-
strated that activation of PKC can occur in the absence of limited
proteolysis by a membrane-associated factor and low Ca2+ con-
centration (3). He then characterized the membrane-associated
factor as diacylglycerol, which is generated by receptor-stimulated
hydrolysis of phosphoinositides, suggesting that this lipid func-
tions as a second messenger (4). These findings and additional
data established a new pathway of signal transduction and led
to identification of biological roles for PKC in signaling path-
ways linked to a variety of surface receptors in many different cell
types.
The PKC family of serine/threonine kinases consists of 10 dis-
tinct isoforms that are differentially expressed in a wide range of
cell types and tissues. Despite having a certain degree of redun-
dancy and overlapping substrate specificities, individual PKC iso-
forms also exhibit non-redundant functions. In addition, activity
of distinct isoforms can be deployed in a spatially and temporally
dependent manner since most isoforms possess a structurally and
differentially activated unique regulatory domain. The activity of
PKC can therefore be induced by a large variety of agonists and
directed by multiple inputs, including second messengers and a
variety of PKC-binding proteins.
This Research Topic focuses on recent developments rele-
vant to the role of PKC in immune cell functions, and includes
contributions by many of the leading experts in the field. The
first paper by Pfeifhofer-Obermair and colleagues (5) reviews
current information related to the physiological role and non-
redundant functions of different PKC isoforms in T lymphocytes.
The authors emphasize the positive contributions of PKCθ (6)
and PKCα (7) to antigen-induced T cell activation and argue that
inhibition T cell-mediated responses, including allograft rejection
and autoimmunity, requires the inhibition of both PKC isoforms.
Black and Black (8) discuss mechanisms of regulation of T cell
proliferation and cell cycle progression that are mediated by dis-
tinct PKC isoforms and emphasize their predominant role during
the G0/G1 and G2 phases. Although PKC was found to modulate
an array of cell cycle regulatory molecules, evidence points to Cdk
kinase inhibitors and D-type cyclins as the key mediators of PKC-
regulated cell cycle-specific effects. The authors indicate that most
PKC isoforms play positive roles during cell cycle progression,
except for PKCδ, which serves as a negative regulator.
Another important cellular function that involves PKC is the
establishment and maintenance of cell polarity. This mecha-
nism enables, among other things, the formation of a functional
immunological synapse (IS) at the T cell-antigen presenting cell
(APC) contact area, and the directional release of cytokines and
cytolytic factors from cytotoxic T cells toward their specific tar-
get cells. The microtubule organizing complex (MTOC) plays an
important role in directing this polarity, and the review by M.
Huse covers the process through which PKC family members
regulate the formation of the MTOC and its link to the T cell
IS (9).
The PKCθ isoform, which is selectively enriched in T cells
(10), is a key modulator of T cell receptor (TCR) signaling and
an essential regulator of T cell activation and survival (11). In
antigen-stimulated T cells, PKCθ selectively translocates to the
center of the IS, where it mediates critical TCR and CD28 signals
leading to the activation of NF-κB, AP-1 and NFAT transcription
factors (12).
A review by Wang and coworkers (13) discusses a major mecha-
nism that regulates PKCθ, and is also shared by other kinases. This
mechanism involves a post-translational process whereby distinct
serine, threonine, and tyrosine residues of PKCθ are autophos-
phorylated or transphosphorylated, thereby regulating its catalytic
activity, as well as its localization within cells and the ability
to interact with specific binding partners. The authors focus on
the actual PKCθ phosphorylation sites and their potential role in
determining PKCθ functions. A short comment on this topic is
presented by Freeley and Long (14).
Another manuscript, by Isakov and Altman (15), focuses on the
molecular mechanism that regulates the translocation of PKCθ to
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the center of the IS. This mechanism was discovered only recently
by showing that a proline-rich region within the unique V3 (hinge)
domain of PKCθ recruits the enzyme to the cytoplasmic tail of
CD28 in a TCR activation-dependent manner (16). The PKCθ-
CD28 interaction is mediated via an indirect mechanism involving
the Lck protein tyrosine kinase as an intermediate. The authors
review progress made in recent years in our understanding of
the PKCθ-mediated signal delivery from the TCR/CD28 surface
receptors.
Another facet of PKCθ relates to its nuclear function in T cells,
where it was found to associate with chromatin in a cell activation-
dependent manner. PKCθ interacts with selected nuclear proteins
with which it forms active complexes that associate with proxi-
mal promoters of inducible T cell genes, including CD69, INF-γ,
and TNF-α (17). The nuclear function of PKCθ and its poten-
tial involvement in specific transcriptional programs in T cells are
discussed by Sutcliffe and colleagues (18).
In addition to the TCR, additional receptors, including OX40,
a member of the tumor necrosis factor receptor (TNFR) super-
family, also utilize PKCθ for signal transmission, a topic that is
presented in this issue by So and Croft (19). Following activation
of T cell-expressed OX40 by its APC-expressed ligand, OX40L,
activated OX40 delivers TCR-independent signals that promote
optimal activation of NF-κB, using signaling intermediates that
are distinct from those utilized by the TCR, e.g., TRAF proteins
and RIP1.
PKCθ-deficient mice serve as an important tool for deci-
phering underlying mechanisms in cellular immune responses.
While in vitro studies of PKCθ-deficient T cells demonstrated
impaired activation responses, in vivo studies indicated that the
requirement for PKCθ is not universal. Anel and colleagues (20)
discuss the involvement of PKCθ in natural killer cell function
and anti-tumor immunity, while the importance of PKCθ dur-
ing the induction of graft-versus-host and graft-versus-leukemia
responses, or in antiviral immunity is reviewed by Bronk and
colleagues (21).
In another review, Sun (22) elaborates on the potential role
of PKCθ in maintaining the normal balance between effector
and regulatory T cells and the possibility of targeting PKCθ
for intervention in T cell responses and prevention of selected
autoimmune diseases and allograft rejection.
Both PKCη and PKCθ are members of the novel PKC subfamily
that are highly expressed in T cells. However, in contrast to PKCθ,
which is concentrated at the center of the IS in activated T cells,
PKCη remains localized in a diffuse pattern over the entire IS,
suggesting distinctive roles for these two isoforms in signal relay
downstream of the TCR. Fu and Gascoigne (23) discuss the spe-
cific roles of PKCη and its functional redundancy with PKCθ in T
cell biology.
Members of the atypical PKC subfamily (aPKC), including
PKCζ and PKCι/λ, are also expressed in lymphocytes and play
important roles in T and B cell differentiation, as well as in the
regulation of T cell polarization and survival. A detailed descrip-
tion of the mechanism of action of aPKCs, in conjunction with
their adapters, p62 and Par-6, in the PB-1-orchestrated signaling
network that regulates lymphocyte behavior, is provide by Martin
and Moscat (24).
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